Balance Sheet

Accounts Payables Accumulated Depreciation Accumulated Expenses Assets Buildings Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Dividends payables Goodwill Goodwill & Intangibles Intangibles Land & Improvements Liabilities and Shareholders Equity Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

Altimmune (ALT) Current Taxes (2016 - 2022)

Historic Current Taxes for Altimmune (ALT) over the last 2 years, with Q3 2022 value amounting to $1.2 million.

Altimmune's Current Taxes changed N/A to $1.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $3.2 million for FY2016, which is N/A changed from last year.
Latest data reveals that Altimmune reported Current Taxes of $1.2 million as of Q3 2022.
Over the past 5 years, Altimmune's Current Taxes peaked at $1.2 million during Q3 2022, and registered a low of $1.2 million during Q3 2022.